This study investigates pancreatic ductal adenocarcinoma. It uses organoids, which are small, simplified versions of organs grown in labs, to study the condition.
The study evaluates how these organoids respond to various chemotherapeutic agents. It looks at the organoid's reaction and compares it to the patient's response to the same treatments.
- Who can participate: Adults over 18 years with pancreatic ductal adenocarcinoma or suspected locally advanced non-metastatic disease, with a life expectancy of more than 3 months, can participate.
- Study details: Participants will undergo a procedure to collect samples for organoid culture. These organoids will be tested with different drug concentrations. A placebo is not involved in this study.
How understandable was the trial content above?
Hard to understand
Easy to understand